Gilead Sciences (NASDAQ:GILD) Coverage Initiated at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $125.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald also issued estimates for Gilead Sciences’ FY2025 earnings at $7.93 EPS. Several other brokerages have […]
Cantor Fitzgerald started coverage on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a research note published on Tuesday, Marketbeat.com reports. The brokerage issued an overweight rating and a $125.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald also issued estimates for Gilead Sciences’ FY2025 earnings at $7.93 EPS. Several other brokerages have […]
